PvP Biologics

Seattle, Washington, USA

Facts

HQ
Seattle, Washington, USA
Sectors
Biotech
Stage
Acquired

Is this your organization? Claim it

Nobel Laureate David Baker Drives Protein Design Innovation and Startup Growth at University of Washington

David Baker, Nobel Prize winner and head of the Institute for Protein Design at the University of Washington, is focused on advancing protein design research and entrepreneurship, having helped spawn over 20 startups in Seattle's biotech hub. He plans to continue accelerating scientific innovation in the field, which develops new proteins for therapeutics, vaccines, and materials.

Xaira Therapeutics Launches Seattle AI Biotech Startup with $1B to Innovate Protein-Based Drug Discovery

Xaira Therapeutics, an AI-driven biotech startup founded in April with over $1 billion in investment, aims to revolutionize drug discovery using protein design technologies developed at the University of Washington’s Institute for Protein Design. Led by Hetu Kamisetty in Seattle, the company integrates AI models like RFDiffusion and ProteinMPNN to create new protein-based therapeutics, tapping into the growing market of biologics that accounted for a third of drug approvals in 2022.

See all 12 news stories about PvP Biologics.